Literature DB >> 22214356

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum.

Patricia Lillo1, Sharon Savage, Eneida Mioshi, Matthew C Kiernan, John R Hodges.   

Abstract

Our objective was to compare the cognitive and behavioural profile of patients with amyotrophic lateral sclerosis (ALS) and behavioural variant frontotemporal dementia (bvFTD), and to explore the continuum between these disorders according to neuropsychological and behavioural performance using novel methods of testing and analysis. Twenty patients with ALS, 20 bvFTD patients and 20 healthy controls completed a neuropsychiatric and neuropsychological assessment including cognitive screening, working memory, inhibitory control, decision making and emotion recognition. The resulting neuropsychological and behavioural data were analysed by Rasch analysis. ALS patients showed a similar profile to bvFTD patients on tests of working memory, inhibitory control and behavioural measures. Nine ALS patients (45%) had cognitive impairment and five (25%) met criteria for bvFTD. Even in a subset of MND patients with no impairment on the ACE-R, subtle impairment of inhibitory control together with moderate to severe apathy, were found. The Rasch analysis confirmed that all patients could be ranked on the same continuum, based on their neuropsychological performance and behaviour. Thus, the cognitive and behavioural profiles of ALS mirror those seen in bvFTD. Impaired inhibitory control and behavioural changes suggest subtle orbitofrontal dysfunction in ALS. The Rasch analysis revealed a clear overlap between bvFTD and ALS.

Entities:  

Mesh:

Year:  2012        PMID: 22214356     DOI: 10.3109/17482968.2011.639376

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  38 in total

1.  Body mass index delineates ALS from FTD: implications for metabolic health.

Authors:  R M Ahmed; E Mioshi; J Caga; M Shibata; M Zoing; L Bartley; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2014-06-24       Impact factor: 4.849

2.  Depression in amyotrophic lateral sclerosis.

Authors:  Elin Roos; Daniela Mariosa; Caroline Ingre; Cecilia Lundholm; Karin Wirdefeldt; Per M Roos; Fang Fang
Journal:  Neurology       Date:  2016-04-22       Impact factor: 9.910

Review 3.  Misregulated RNA processing in amyotrophic lateral sclerosis.

Authors:  Magdalini Polymenidou; Clotilde Lagier-Tourenne; Kasey R Hutt; C Frank Bennett; Don W Cleveland; Gene W Yeo
Journal:  Brain Res       Date:  2012-03-03       Impact factor: 3.252

4.  An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies.

Authors:  Grant Coan; Cassie S Mitchell
Journal:  Neurodegener Dis       Date:  2015-07-16       Impact factor: 2.977

Review 5.  The neuropathological signature of bulbar-onset ALS: A systematic review.

Authors:  S Shellikeri; V Karthikeyan; R Martino; S E Black; L Zinman; J Keith; Y Yunusova
Journal:  Neurosci Biobehav Rev       Date:  2017-02-02       Impact factor: 8.989

Review 6.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Authors:  Michael J Strong; Sharon Abrahams; Laura H Goldstein; Susan Woolley; Paula Mclaughlin; Julie Snowden; Eneida Mioshi; Angie Roberts-South; Michael Benatar; Tibor HortobáGyi; Jeffrey Rosenfeld; Vincenzo Silani; Paul G Ince; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-01-05       Impact factor: 4.092

7.  Narrative discourse deficits in amyotrophic lateral sclerosis.

Authors:  Sharon Ash; Anna Menaged; Christopher Olm; Corey T McMillan; Ashley Boller; David J Irwin; Leo McCluskey; Lauren Elman; Murray Grossman
Journal:  Neurology       Date:  2014-07-02       Impact factor: 9.910

8.  Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival.

Authors:  R M Ahmed; J Caga; E Devenney; S Hsieh; L Bartley; E Highton-Williamson; E Ramsey; M Zoing; G M Halliday; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

9.  Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Authors:  Jennifer Murphy; Pam Factor-Litvak; Raymond Goetz; Catherine Lomen-Hoerth; Peter L Nagy; Jonathan Hupf; Jessica Singleton; Susan Woolley; Howard Andrews; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Boguslawa A Koczon-Jaremko; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-01-22       Impact factor: 9.910

10.  Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.

Authors:  Giulia Vinceti; Nicholas Olney; Maria Luisa Mandelli; Salvatore Spina; H Isabel Hubbard; Miguel A Santos-Santos; Christa Watson; Zachary A Miller; Catherine Lomen-Hoerth; Paolo Nichelli; Bruce L Miller; Lea T Grinberg; William W Seeley; Maria Luisa Gorno-Tempini
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-01-22       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.